美股市场个股详情
NVRO Nevro
- 4.580
- +0.260+6.02%
收盘价 11/27 16:00 (美东)
- 4.370
- -0.210-4.59%
盘后 20:01 (美东)
1.72亿总市值-2449市盈率TTM
4.610最高价4.340最低价34.36万股成交量4.340今开4.320昨收156.43万成交额0.94%换手率亏损市盈率(静)3747.16万总股本22.64052周最高0.63市净率1.67亿流通值3.95052周最低--股息TTM3640.21万流通股188.140历史最高--股息率TTM6.25%振幅3.950历史最低4.553平均价1股每手
关于Nevro公司
Nevro Corp 是一家医疗设备公司。 其主要产品是 HFX 脊髓刺激 (SCS) 平台，其中包括 Senza SCS 系统，这是一种用于治疗慢性疼痛的循证神经调节系统。 Senza 产生电脉冲来缓解疼痛。 该系统由医生植入，由患者控制。 它由导线、试验刺激器、植入式脉冲发生器、手术工具、临床医生笔记本电脑编程器、患者遥控器和移动充电器组成。 该公司的大部分收入来自美国。
公司介绍
公司代码NVRO
公司名称Nevro
上市日期2014/11/06
发行价格18.00
成立日期2006
CEOMr. Kevin R. Thornal
所属市场纽交所
员工数量1215
年结日12-31
公司地址1800 Bridge Parkway
城市Redwood City
省份加利福尼亚州
国家美国
邮编94065
电话1-650-251-0005
董事高管
- 姓名
- 职务
- 年薪
- Kevin R. Thornal
- Director, Chief Executive Officer and President
- 1145.35万
- Dr. David Caraway, PhD
- Senior Vice President and Chief Medical Officer
- --
- Shana Ross
- Senior Vice President and Chief Human Resources Officer
- --
- Christopher Christoforou
- Chief Operating Officer
- --
- Greg Siller
- Senior Vice President and Chief Commercial Officer
- 355.81万
- Kashif Rashid
- Senior Vice President, Corporate Development and Chief Legal Officer
- 255.37万
- Roderick H. MacLeod
- Senior Vice President and Chief Financial Officer
- 257.72万
- Donald A. Middlebrook
- Senior Vice President, Clinical, Regulatory and Quality
- --
- Peter A. Socarras
- Vice President, General Counsel and Corporate Secretary
- --
- D. Keith Grossman
- Non-Executive Chairman of the Board
- 136.44万
- Karen N. Prange
- Independent Director
- 25.30万
- Michael F. DeMane
- Lead Independent Director
- 28.50万
- Kevin O’Boyle
- Independent Director
- 26.00万
- Shawn T. McCormick
- Independent Director
- 24.70万
- Kirt P. Karros
- Independent Director
- --
- Susan E. Siegel
- Independent Director
- 24.30万
- Sri Kosaraju
- Independent Director
- 24.30万
- Elizabeth H. Weatherman
- Independent Director
- 25.92万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据